Lung cancer risk by years since quitting in 30+ pack year smokers

Journal of Medical Screening

Volumn 22, Issue 3, 2015, Pages 151-157

  Pinsky, Paul F ^a   Zhu, Claire S ^a   Kramer, Barnett S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Low dose CT; Lung cancer; Smoking; Years since quit

Indexed keywords

ADVERSE EFFECTS; COMPUTER ASSISTED TOMOGRAPHY; EARLY CANCER DIAGNOSIS; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; PROCEDURES; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; RADIOGRAPHY; RISK; SMOKING; SMOKING CESSATION; THORAX RADIOGRAPHY; TIME FACTOR; UNITED STATES;

EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MASS SCREENING; PROPORTIONAL HAZARDS MODELS; RADIOGRAPHY, THORACIC; RISK; SMOKING; SMOKING CESSATION; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; UNITED STATES;

EID: 84958968042     PISSN: 09691413     EISSN: 14755793     Source Type: Journal    
DOI: 10.1177/0969141315579119     Document Type: Article

References (15)

1. Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Int Med 2014;160:330-338.
2. National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
3. Center for Medicare Services. National Coverage Analysis for screening for lung cancer with low dose computed tomography (LDCT). http://www.cms.gov/medicare-coveragedatabase/details/nca-details.aspx?NCAId=274 (accessed 7 February 2015).
4. American Cancer Society. American Cancer Society guidelines for the early detection of cancer. http://www.cancer.org/healthy/findcancerearly/cancerscreeningguidelines/americancancer-society-guidelines-for-the-early-detection-of-cancer (accessed 23 December 2014).
5. Peto R, Darby S, Deo H, et al. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case control studies. Br Med J 2000;321:323-329.
6. Halperin MT, Gillespie BW, Warner KE. Patterns of absolute risk of lung cancer mortality in former smokers. J National Cancer Inst 1993;85:457-464.
7. Knoke JD, Burns DM, Thun MJ. The change in excess risk of lung cancer attributable to smoking following smoking cessation: an examination of different analytic approaches to using CPS-I data. Cancer Causes Control 2008;19:207-219.
8. Fry JS, Lee PN, Forey BA, et al. How rapidly does the excess risk of lung cancer decline following quitting smoking? A quantitative review using the negative exponential model. Regul Toxicol Pharmacol 2013;67:13-26.
9. Prorok PC, Andriole GL, Bresalier RS, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Controlled Clinical Trials 2000;21(Suppl 6): 273S-309S.
10. Oken MM, Hocking WG, Kvale PA, et al. Screening by chest radiograph and lung cancer mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA 2011;306(17):1865-1873.
11. Villanti AC, Jiang Y, Abrams DB, et al. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLOS ONE 2013;8(8):e71379.
12. Black WC, Gareen IF, Soneji SS, et al. Cost-effectiveness of CT screening in the National Lung Screening Trial. New Engl J Med 2014;371:1793-1802.
13. Gohagan J, Marcus P, Fagerstrom R, et al. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph. Chest 2004;126:114-121.
14. Horeweg N, van der Aalst CM, Vliegenthart R, et al. Volumetric computed tomography screening for lung cancer: three rounds of the NELSON trial. Eur Respir J 2013;42:1659-1667.
15. Pinsky PF, Berg C. Applying the National Lung Screening Trial eligibility criteria to the US. population: what percent of the population and of incident cancers would be covered? J Med Screen 2012;19:154-156.